| Initial treatment strategy | CN assignment | |||||||
---|---|---|---|---|---|---|---|---|---|
 | Total n = 2614 | Curative n = 877 | Palliative n = 1278 | No tumour-directed treatment n = 459 | p-value1 | Total n = 1256 | Yes n = 955 (76.0%) | No n = 301 (24.0%) | p-value2 |
Hospital stays, median (Q1–Q3) | |||||||||
 Unplanned | 2.0 (1.0–4.0) | 3.0 (2.0–5.0) | 2.0 (1.0–3.0) | 1.0 (1.0–2.0) | < 0.0011 | 2.0 (1.0–4.0) | 2.0 (1.0–3.0) | 1.0 (1.0–2.0) | 0.007 |
 Planned | 1.0 (0.0–2.0) | 2.0 (1.0–3.0) | 1.0 (0.0–1) | 0.0 (0.0–1.0) | < 0.0011 | 1.0 (0.0–2.0) | 1.0 (0.0–2.0) | 0.0 (0.0–1.0) | 0.024 |
 Total (unplanned and planned) | 3.0 (2.0–6.0) | 5.0 (3.0–8.0) | 3.0 (1.0–4.0) | 1.0 (1.0–2.0) | < 0.0011 | 4.0 (2.0–7.0) | 3.0 (1.0–4.0) | 2.0 (1.0–4.0) | < 0.001 |
 Bed days | 24.0 (10.0–47.0) | 46.0 (28.0–70.0) | 20.0 (8.0–36.0) | 8.0 (2.0–19.0) | < 0.0011 | 32.0 (14.0–56.0) | 19.0 (8.0–37.0) | 14.0 (4.0–29.0) | < 0.001 |
Visits, specialist outpatient care, median (Q1–Q3) | |||||||||
 Unplanned | 1.0 (0.0–3.0) | 2.0 (1.0–4.0) | 1.0 (0.0–2.0) | 0.0 (0.0–1.0) | < 0.0011 | 1.0 (0.0–2.0) | 1.0 (0.0–2.0) | 0.0 (0.0–2.0) | < 0.001 |
 Planned | 6.0 (2.0–14.0 | 13.0 (7.0–23.5) | 5.0 (2.0–12.0) | 1.0 (0–2.0) | < 0.0011 | 4.0 (1.0–10.0) | 4.0 (1.0–10.0) | 2.0 (0.0–10.0) | < 0.001 |
 Total (unplanned and planned) | 8.0 (3.0–17.0) | 16.0 (9.0–28.0) | 7.0 (3.0–14.0) | 1 (0.0–3.0) | < 0.0011 | 5.0 (2.0–13.0) | 6.0 (2.0–13.0) | 3.0 (0.0–12.0) | < 0.001 |